ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 641461 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 641461; 2) Community: the network communities that were significantly associated with the response to NSC 641461; 3) Molecule: the relationships between components within communities and NSC 641461; 4) MDR: the compounds that were significantly associated with the NSC 641461.

NSC Compound Enrichment Correlation
NSC 681633 Camptothecin Derivative 0.0135588245836371 0.64050845
NSC 683039 Immunotoxin e23(dsFv)-PE38, anti-c-erbB-2 disulfide -stabilized Fv genetically fused to truncated form of Pseudomonas exotoxin 0.0135588245836371 -0.017747406
NSC 683517 8H-Thieno[2,3-b]pyrrolizinium, 3-(4-bromophenyl)-4-methyl- 8-(1-pyrrolidinyl)-, iodide 0.0135588245836371 0.18902656
NSC 683556 Camptothecin Derivative 0.0135588245836371 0.57608929
NSC 692332 Null 0.0135588245836371 0.34911581
NSC 693883 Acetaldehyde, 1-chloro-, O-[[(4-fluoro-3-nitrophenyl) amino]carbonyl]oxime 0.0135588245836371 0.13634361
NSC 697730 Null 0.0135588245836371 0.11714631
NSC 700363 Liposomal Annamycin 0.0135588245836371 0.52433225
NSC 704562 Null 0.0135588245836371 -0.090304248
NSC 705941 Null 0.0135588245836371 0.049800434
Total:68  Current:16    [First] [Prev] [Next] [Last]